Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy...
Transcript of Understanding Temporal Patterns · Understanding Temporal Patterns in Hypertensive Drug Therapy...
Understanding Temporal Patternsin Hypertensive Drug Therapy
1Margret Bjarnadottir, 2Sana Malik, 2Catherine Plaisant, 3Eberechukwu Onukwugha
1Smith School of Business, University of Maryland, College Park 2Department of Computer Science, University of Maryland, College Park 3School of Pharmacy, University of Maryland, Baltimore
May 28, 2015 — HCIL 32nd Annual Symposium
2
๏ Worsened conditions
๏ Adverse outcomes
๏ Increased risk of death
Hospitalization costs due to medication non-adherence are estimated as high as
$13 billion annually.
3
Sullivan et al., “Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate,” Journal of Research in Pharmaceutical Economics, Vol. 2, No. 2. (1990), pp. 19-33.
Medication Possession Ratio (MPR)
4
period nobservatio of lengthsupplied days∑
Medication Possession Ratio (MPR)
4
period nobservatio of lengthsupplied days∑
time
Study start Study end
Medication Possession Ratio (MPR)
4
period nobservatio of lengthsupplied days∑
time
Study start Study end
= 100%
Medication Possession Ratio (MPR)
4
period nobservatio of lengthsupplied days∑
time
Study start Study end
= 83%
Medication Possession Ratio (MPR)
5
period nobservatio of lengthsupplied days∑ = 75%
time
Study start Study end
Hypertensive Drug Therapy
Angiotension-Converting Enzyme-Inhibitors
Angiotension II Receptor Blockers
Calcium Channel Blockers
Beta Blockers
Diuretics
6
ACE
ARB
CCB
Beta
Diur
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
time
Hypertensive Drug Therapy
Can we use visualization tools to more accurately understand adherence
patterns in hypertensive drug therapy?
11
๏ Can we identify good vs. bad patterns?
๏ Can we understand patient behavior?
Research Questions
Data๏ Commercial prescription claims
๏ 900,000 individuals (16 million claims)
๏ 5 Drug Classes
12
Angiotension-Converting Enzyme-Inhibitors
Angiotension II Receptor Blockers
Calcium Channel Blockers
Beta Blockers
Diuretics
ACE
ARB
CCB
Beta
Diur
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
13
14
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging Dataset
14
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
— Single
} 2 Drugs
} 3 Drugs
} 4 Drugs
— All 5
15
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
timeStart of record
15
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
time2 yearsStart of record
16
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
time
16
Data Simplification
๏ Partitioning
๏ Temporal Windowing
๏ Interval Merging
time
How do allowable gap and overlap assumptions affect adherence
analysis?
Sensitivity Analysis: Allowable Gap
18
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Gap
18
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Gap
18
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Gap
18
0 days 7 days
15 days 30 days
19
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Overlap
19
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Overlap
19
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Overlap
19
0 days 7 days
15 days 30 days
Sensitivity Analysis: Allowable Overlap
20
Single DrugsACE
ARB
CCB
Beta
Diur
20
Single DrugsACE
ARB
CCB
Beta
Diur
21
2 DrugsACE
Beta
Both
21
2 DrugsACE
Beta
Both
22
2 Drugs
false overlap
ACE
Beta
Both
23
2 DrugsACE
Beta
Both
24
2 DrugsACE
Beta
Both
All 5 Drugs
25
2,200 patients
2,200 patientsAll 5 Drugs
26
2,200 patientsAll 5 Drugs
26
2,200 patientsAll 5 Drugs
26
2,200 patientsAll 5 Drugs
26
All 5 Drugs
27
2,200 patients
All 5 Drugs
27
2,200 patients
Starting on Diuretic
28
ACE
ARB
CCB
Beta
Diur150,000 patients
Starting on Diuretic
28
ACE
ARB
CCB
Beta
Diur150,000 patients
Starting on Diuretic
28
ACE
ARB
CCB
Beta
Diur150,000 patients
Summary
๏ Visualization facilitated rapid understanding of complex patient behavior
๏ Interactions allow systematic analysis of episode modeling
29
30
Understanding Temporal Patternsin Hypertensive Drug Therapy
Sana [email protected]/hcil/eventflow
Thanks to Sophia Wu. Support from the University of Maryland Center for Health-related Informatics and Bioimaging (CHIB).